Simulations Plus Reports Mixed Q3 2026 Results Amid Altaris Acquisition
Event summary
- Total revenue increased 7% YoY to $21.9M in Q3 2026, with services revenue up 20% and software revenue flat.
- Net income swung to a profit of $3.6M from a loss of $67.3M in the prior-year quarter.
- Adjusted EBITDA margin held steady at 36% of total revenue.
- Company agreed to be acquired by Altaris, LLC for an undisclosed sum, with expected closing in Q4 2026.
The big picture
Simulations Plus's Q3 results highlight a strategic shift toward services-driven revenue amid broader industry trends in model-informed and AI-accelerated drug development. The Altaris acquisition positions the company for potential expansion, but integration risks loom as it navigates this transition.
What we're watching
- Integration Challenges
- How the pending Altaris acquisition will impact Simulations Plus's operational focus and strategic direction.
- Revenue Diversification
- Whether the company can sustain its services revenue growth while maintaining software stability.
- Market Positioning
- The pace at which Simulations Plus can expand its AI-accelerated drug development solutions under new ownership.
Related topics
